Triumvira Immunologics
Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.
$45M Series A ·
Led by B Capital · Source: startupintros.com
Total raised: $100M across 2 sourced rounds
All 2 rounds ↓Signals
Triumvira Immunologics | 2299 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $45M | startupintros.com | ||
| Series A | $55M | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
JB
Jonathan Bramson FounderPL
Paul Lammers President & CEOAB
Andreas Bader Chief Scientific OfficerJI
Jon Irvin Senior Vice President of FinancePC
Pedro Correa de Sampaio Project ConsultantRW
Robert Williamson President and CBOSC
Sabine Chlosta Chief Medical Officer
Investors
AATEM Capital Fund LP
BB Capitallead investor
BBloom Burton & Co.
CCentre for Commercialization of Cancer Immunotherapy
LLeaps by Bayerlead investor
MMultiple Myeloma Research Foundation
MMyeloma Investment Fund
NNorthpond Ventureslead investor
OOceanpine Capital
- VViva Biotech
Companies like Triumvira Immunologics
MMariana Oncology$175M Series B+ · Sep 2023
SSwarm OncologySeed · Mar 2026
TTinkeso TherapeuticsKKaliVir Immunotherapeutics$14M Series A · Aug 2026
UUmoja Biopharma$100M Series B+ · Jan 2025
AAffini-T$175M Series A · Mar 2022
Other companies backed by B Capital
PProject Omega$80M Series A · Nov 2026
LLabelbox$100M Series B+ · Oct 2026
SSonilo$11M Seed · Oct 2026
PPaleBlueDot AI$200M Series B+ · Oct 2026
TTiny Health$33M Series B+ · Sep 2026
PPrecision Neuroscience$250M Series B+ · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/triumvira-immunologics (get a free API key).